Ending AIDS by 2030 a distant prospect, global HIV incidence, prevalence, treatment coverage and mortality figures suggest
AbbVie 3D and 2D hepatitis C combos work well for people with HIV and HCV co-infection
START analysis looks at who benefits most from immediate HIV treatment
High Court rules NHS England is responsible for funding PrEP
Training community health workers to perform intensified TB case finding associated with a surge in TB diagnoses in a rural Malawi study
Searching for the next ‘Berlin patient’: doctors document bone-marrow recipients with HIV
The importance of voluntary in-house HIV testing
PrEP rollout recipients in France top 1000: full trial results report 97% effectiveness
Stigma persists in the undetectable era
